February 20, 2011
February 14, 2011 09:00 AM Eastern Time EWING, N.J.–(BUSINESS WIRE)–Antares Pharma, Inc. (NYSE Amex: AIS) today announced the receipt from the U.S. Food and Drug Administration (FDA) of a waiver, on February 8, 2011, for the $1,500,000 New Drug Application (NDA) filing fee for AnturolĀ® Gel for overactive bladder (OAB). “We are pleased to have received [...]
Read the full article →
February 20, 2011
In some instances it appears as though depends upon is in fact closing around upon you and there is no escape and it also is similar to you really can’t inhale the air. it doesn’t matter what one does it is difficult to quit stressing, and yes it is similar to you’ll find nothing that’ll [...]
Read the full article →